Inflammation-mediated deacetylation of the ribonuclease 1 promoter


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 1 5 2019
medline: 2 6 2020
entrez: 1 5 2019
Statut: ppublish

Résumé

Ribonuclease 1 (RNase1) is a circulating extracellular endonuclease that regulates the vascular homeostasis of extracellular RNA and acts as a vessel- and tissue-protective enzyme. Upon long-term inflammation, high amounts of proinflammatory cytokines affect endothelial cell (EC) function by down-regulation of RNase1. Here, we investigated the transcriptional regulation of RNase1 upon inflammation in HUVECs. TNF-α or IL-1β stimulation reduced the expression of RNase1 relative to the acetylation state of histone 3 at lysine 27 and histone 4 of the

Identifiants

pubmed: 31039328
doi: 10.1096/fj.201900451R
doi:

Substances chimiques

Benzamides 0
Chromatin 0
Histone Deacetylase Inhibitors 0
Inflammation Mediators 0
Pyridines 0
RNA, Messenger 0
Tumor Necrosis Factor-alpha 0
entinostat 1ZNY4FKK9H
Ribonuclease, Pancreatic EC 3.1.27.5
HDAC1 protein, human EC 3.5.1.98
HDAC2 protein, human EC 3.5.1.98
Histone Deacetylase 1 EC 3.5.1.98
Histone Deacetylase 2 EC 3.5.1.98

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9017-9029

Auteurs

Katrin Bedenbender (K)

Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.

Nicoletta Scheller (N)

Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.

Silvia Fischer (S)

Department of Biochemistry, Faculty of Medicine, Justus-Liebig-University, Giessen, Germany.

Silke Leiting (S)

Department of Biochemistry, Faculty of Medicine, Justus-Liebig-University, Giessen, Germany.

Klaus T Preissner (KT)

Department of Biochemistry, Faculty of Medicine, Justus-Liebig-University, Giessen, Germany.

Bernd T Schmeck (BT)

Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.
Department of Pulmonary and Critical Care Medicine, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.

Evelyn Vollmeister (E)

Institute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL), Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH